Applied Dna Sciences (NASDAQ:BNBX) Issues Quarterly Earnings Results

Applied Dna Sciences (NASDAQ:BNBX) posted its earnings results on Thursday. The company reported ($2.08) earnings per share for the quarter, Zacks reports. Applied Dna Sciences had a negative return on equity of 191.67% and a negative net margin of 399.91%.

Applied Dna Sciences Stock Performance

NASDAQ:BNBX traded down $0.06 on Thursday, reaching $0.80. 47,820 shares of the stock traded hands, compared to its average volume of 211,622. Applied Dna Sciences has a 1-year low of $0.79 and a 1-year high of $142.20. The company has a market capitalization of $3.49 million, a PE ratio of 0.00 and a beta of 0.57.

Wall Street Analyst Weigh In

Separately, Weiss Ratings started coverage on shares of Applied Dna Sciences in a report on Monday, January 26th. They set a “sell (e+)” rating on the stock. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company presently has a consensus rating of “Sell”.

About Applied Dna Sciences

Applied DNA Sciences is a U.S.-based biotechnology company that develops and commercializes molecular-level solutions for product authentication, supply chain security and forensic identification. The company’s technologies apply unique DNA markers and laboratory testing methods to tag, track and verify the authenticity of goods and materials, with the goal of combating counterfeiting, diversion and fraud across complex supply chains.

Central to Applied DNA’s offering is a suite of proprietary DNA-based markers and associated assays that can be incorporated into inks, fibers, coatings and other substrates to create tamper-evident, forensic-grade identifiers.